Ingenza announced that the company has reached a technical milestone with Syngenta in their collaboration to develop efficient manufacturing technologies for crop protection products.

Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences have developed a metasurface which is a new tool to study novel aspects of light.

With an aim to protect patients detected with Covid-19 from all over the world, Pfizer and Biontech have entered into a letter of intent to create a potential vaccine for Coronavirus. Under the terms of the agreement, BNT162 – Biontech’s Covid-19 mrna vaccine programme will be fast-tracked and will enter clinical testing towards the end of April 2020.

Testing of the potential covid-19 vaccine – mrna-1273 developed by the National Institutes of Health and biotechnology firm Moderna has started in the USA. If the research proves successful, the company will be able to mass produce the cure only after 12 to 18 months.

The German-biopharmaceutical company Curevac is working on developing an mrna-based vaccine that is strong, effective, safe and quick to produce against Covid-19. For this propose, the company is already in touch with numerous organisations and authorities across the globe.

Pfeiffer Vacuum, in cooperation with The European X-Ray Free-Electron Laser (European XFEL), developed solutions ranging from vacuum pumps to leak detectors to vacuum components for many vacuum applications at the research facility.

A solution jointly developed by Henkel and Covestro is intended to enable the efficient assembly of cylindrical Li-ion battery cells in a plastic cell holder.

By exploiting the power of high-performance computing of the supercomputer Shaheen II, researchers at the King Abdullah University in Saudi Arabia (Kaust) developed a new statistical tool that could reduce the cost and improve the accuracy of analyzing large environmental and climate datasets.

There are currently 445 chimeric antigen receptor (CAR-T cell) therapies under development by companies headquartered across the Asia-Pacific (Apac) region. With research in progress and increased understanding of cancer biology, the new therapies are expected to make the global market more competitive and cost effective, says Global Data.

The aim of the European Plastics Pact is to improve the use of plastics as well as its recycling. Signatories of this pact are expected to develop new techniques and approaches, share knowledge, harmonise guidelines and standards, and reduce current barriers for this purpose.